Lunit Inc. (328130.KQ) — Stock Score Summary

Lunit Inc. (328130.KQ) has a MoatMap StockRank of 9/100 based on Quality (22/100), Value (35/100), and Momentum (32/100) factor scores. The current signal is STRONG SELL.

Lunit Inc. provides AI-powered software and solutions for cancer diagnostics and therapeutics in South Korea. It offers AI solution for chest X-ray and mammography, as well as AI solution for digital breast tomosynthesis, and AI-powered biomarker for immune phenotyping and PD-L1 biomarker analyzer.

Key Financial Metrics

Price$10.52
Market Cap$746M
P/E (Forward)-18.01
Price/Book7.28
Return on Equity-45.3%
Return on Invested Capital-13.4%
Debt/Equity118.56
Gross Margin100.0%
Operating Margin-56.8%
Revenue Growth24.7%
Free Cash Flow$-40K

Lunit Inc. operates in the Health Information Services industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is Lunit Inc.’s (328130.KQ) StockRank?
MoatMap’s StockRank for Lunit Inc. (328130.KQ) is 9/100, with a Strong Sell signal. It is a composite of Quality (22), Value (35), and Momentum (32) factor ranks across MoatMap’s 19,000+ stock universe.
Does Lunit Inc. have an economic moat?
Lunit Inc. (328130.KQ) has a Quality factor score of 22/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Lunit Inc. a buy, hold, or sell?
MoatMap’s current signal for Lunit Inc. (328130.KQ) is Strong Sell, based on a StockRank of 9/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Lunit Inc. in?
Lunit Inc. (328130.KQ) operates in the Healthcare sector, specifically the Health Information Services industry (South Korea).